Literature DB >> 23413299

Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints.

Tram Kim Lam1, Sheri D Schully, Scott D Rogers, Rachel Benkeser, Britt Reid, Muin J Khoury.   

Abstract

In a time of scientific and technological developments and budgetary constraints, the National Cancer Institute's (NCI) Provocative Questions Project offers a novel funding mechanism for cancer epidemiologists. We reviewed the purposes underlying the Provocative Questions Project, present information on the contributions of epidemiologic research to the current Provocative Questions portfolio, and outline opportunities that the cancer epidemiology community might capitalize on to advance a research agenda that spans a translational continuum from scientific discoveries to population health impact.

Entities:  

Mesh：

Year:  2013        PMID： 23413299      PMCID： PMC4693604          DOI： 10.1158/1055-9965.EPI-13-0101

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


  6 in total

1.  Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute.

Authors:  Muin J Khoury; Andrew N Freedman; Elizabeth M Gillanders; Chinonye E Harvey; Christie Kaefer; Britt C Reid; Scott Rogers; Sheri D Schully; Daniela Seminara; Mukesh Verma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

2.  Science funding: Provocative questions in cancer research.

Authors:  Harold Varmus; Ed Harlow
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

3.  Time for a creative transformation of epidemiology in the United States.

Authors:  Michael S Lauer
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

4.  Ecological public health: the 21st century's big idea? An essay by Tim Lang and Geof Rayner.

Authors:  Tim Lang; Geof Rayner
Journal:  BMJ       Date:  2012-08-21

5.  Integrative cancer epidemiology--the next generation.

Authors:  Margaret R Spitz; Neil E Caporaso; Thomas A Sellers
Journal:  Cancer Discov       Date:  2012-12       Impact factor: 39.397

6.  "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Authors:  Tram Kim Lam; Margaret Spitz; Sheri D Schully; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-15       Impact factor: 4.254
  6 in total
  3 in total

Review 1.  Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology.

Authors:  S Ogino; P Lochhead; E Giovannucci; J A Meyerhardt; C S Fuchs; A T Chan
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

2.  Transforming epidemiology for 21st century medicine and public health.

Authors:  Muin J Khoury; Tram Kim Lam; John P A Ioannidis; Patricia Hartge; Margaret R Spitz; Julie E Buring; Stephen J Chanock; Robert T Croyle; Katrina A Goddard; Geoffrey S Ginsburg; Zdenko Herceg; Robert A Hiatt; Robert N Hoover; David J Hunter; Barnet S Kramer; Michael S Lauer; Jeffrey A Meyerhardt; Olufunmilayo I Olopade; Julie R Palmer; Thomas A Sellers; Daniela Seminara; David F Ransohoff; Timothy R Rebbeck; Georgia Tourassi; Deborah M Winn; Ann Zauber; Sheri D Schully
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

3.  Recognizing that Evidence is Made, not Born.

Authors:  Robyn Lim; David K Lee; Pierre Sabourin; John Ferguson; Marilyn Metcalf; Meredith Smith; Solange Corriol-Rohou; Hans-Georg Eichler; Murray Lumpkin; Gigi Hirsch; Inhua Muijrers Chen; Brian O'Rourke; Anja Schiel; Nick Crabb; Naomi Aronson; Edmund Pezalla; Marc Boutin; Louise Binder; Linda Wilhelm
Journal:  Clin Pharmacol Ther       Date:  2019-01-04       Impact factor: 6.875
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.